Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Epirubicin × Clear all

NCT06421948 2025-12-05

Linperlisib Combined With Chidamide in Patients With PTCL

Phase 1/2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT04213898 2019-12-30

SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer

Phase 1/2 Unknown

Triple Negative Breast Neoplasms